| 5867 |
Centers for Disease Control and Prevention |
Html |
en |
Dimethylamine - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6938 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Namibia |
CDC has collaborated with the government of Namibia since 2002, to support the national response to the HIV epidemic. |
| strategic information | 0.675456 |
| line | 0.445917 |
| Country Health Profiles | 0.670805 |
| National Strategic Framework | 0.63179 |
| Source | 0.456 |
| capacity | 0.462804 |
| systems | 0.454082 |
| MoHSS | 0.501044 |
| Population Reference Bureau | 0.674425 |
| national public health | 0.878932 |
| CDC-Namibia | 0.537203 |
| workforce | 0.47008 |
| treatment services | 0.53023 |
| AIDS-free generation | 0.53657 |
| comprehensive portfolio | 0.670525 |
| mother-to-child transmission | 0.53712 |
| NSF | 0.428962 |
| HIV/AIDS prevention | 0.98313 |
|
| targeted technical assistance | 0.653063 |
| UNAIDS | 0.435915 |
| accordance | 0.428379 |
| Social Services | 0.696916 |
| comprehensive package | 0.689075 |
| PEPFAR mission | 0.537754 |
| treatment programs | 0.666136 |
| HIV program | 0.553309 |
| AIDS Response | 0.535801 |
| Namibian Ministry | 0.74445 |
| HIV/AIDS epidemic | 0.577144 |
| partners | 0.425849 |
| public health sector | 0.897304 |
| biomedical transmission | 0.536817 |
| support | 0.446659 |
| care | 0.535402 |
| national efforts | 0.533144 |
|
CLICK HERE |
| 7200 |
Centers for Disease Control and Prevention |
Html |
en |
Basic Information About Ovarian Cancer |
Basic information about ovarian cancer from CDC. |
| ovarian cancer incidence | 0.662992 |
| abnormal cells | 0.492115 |
| ovaries | 0.457455 |
| United States | 0.474953 |
| early stages | 0.478557 |
| abdomen | 0.420524 |
| changes | 0.413194 |
| pelvis | 0.421269 |
| areas | 0.414445 |
| Asian/Pacific Islander | 0.482035 |
| cancer susceptibility genes | 0.560102 |
| uterus | 0.481032 |
| mutations | 0.435099 |
| signs | 0.413544 |
| variety | 0.412787 |
| Ovarian cancers | 0.596323 |
| ovarian cancer risk | 0.667889 |
| Indian/Alaska Native women | 0.54384 |
| treatment works | 0.480196 |
| health care | 0.478108 |
| deaths | 0.413679 |
| Lynch syndrome | 0.47711 |
| group | 0.414496 |
| BRCA tool | 0.473879 |
|
| different races | 0.471131 |
| eggs | 0.433324 |
| peritoneum | 0.428562 |
| organs | 0.413583 |
| different tumor types | 0.539137 |
| disease | 0.415586 |
| ovarian cancer | 0.94661 |
| body parts | 0.489635 |
| diseases | 0.414488 |
| common tumor type | 0.539988 |
| control | 0.41554 |
| tissue lining | 0.480222 |
| ethnic backgrounds | 0.4702 |
| pair | 0.415166 |
| way | 0.41334 |
| female hormones | 0.484426 |
| symptoms | 0.427253 |
| doctor | 0.413313 |
| BRCA gene mutation | 0.536331 |
| fallopian tubes | 0.69098 |
| highest incidence | 0.4767 |
| ovarian cancer cases | 0.662105 |
| slender tubes | 0.498316 |
|
CLICK HERE |
| 7211 |
Centers for Disease Control and Prevention |
Html |
en |
Updated CDC Recommendations for the Management of Hepatitis B Virus-Infected Health-Care Providers and Students |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| HBV replication | 0.512796 |
| HBV health-care | 0.577678 |
| median HBV DNA | 0.558794 |
| serum HBV DNA | 0.577872 |
| infected health-care providers | 0.556239 |
| active HBV infection | 0.539301 |
| Versant HBV DNA | 0.545175 |
| HBV DNA serum | 0.584355 |
| HBV-infected health-care provider | 0.55522 |
| patient-to-patient HBV transmission | 0.554761 |
| HBV blood levels | 0.551838 |
| HBV DNA blood | 0.597016 |
| undetectable HBV | 0.539485 |
| infected health-care provider | 0.500631 |
| HBV testing | 0.523768 |
| HBV transmission | 0.621267 |
| detectable HBV DNA | 0.543223 |
| Amplicor HBV DNA | 0.545036 |
| HBV strains | 0.523199 |
| HBV infection status | 0.58792 |
| acute HBV infections | 0.547185 |
| HBV serologic status | 0.529024 |
| United States | 0.57781 |
| health-care providers | 0.714696 |
| acute HBV infection | 0.601986 |
|
| health-care personnel | 0.508037 |
| HBV virus levels | 0.554884 |
| exposure-prone invasive procedures | 0.501427 |
| HBV DNA | 0.900354 |
| health care workers | 0.503662 |
| HBV viral load | 0.611431 |
| health-care settings | 0.498287 |
| hepatitis b virus | 0.573332 |
| HBV level | 0.518277 |
| HBV-infected health-care providers | 0.604977 |
| chronic hbv infection | 0.632645 |
| hepatitis | 0.576752 |
| quantitative HBV DNA | 0.544125 |
| expert review panel | 0.529984 |
| HBV status | 0.574784 |
| HBV DNA levels | 0.762482 |
| health-care provider | 0.635245 |
| exposure-prone procedures | 0.703872 |
| mean HBV DNA | 0.54472 |
| provider HBV status | 0.545051 |
| HBV infection | 0.751339 |
| et al | 0.547155 |
| Symptomatic acute HBV | 0.536667 |
| invasive procedures | 0.516573 |
|
CLICK HERE |
| 7482 |
Centers for Disease Control and Prevention |
Html |
en |
Healthy Housing Reference Manual - Chapter 5: Indoor Air Pollutants and Toxic Materials |
NCEH provides leadership to promote health and quality of life by preventing or controlling those diseases, birth defects, or disabilities resulting from interaction between people and the environment. Site has information/education resources on a broad range of topics, including asthma, birth defects, radiation, sanitation, lead in blood, and more. |
| airborne mold contaminants | 0.78907 |
| Mold Standards | 0.779125 |
| mold contamination problems | 0.804144 |
| different mold species | 0.800007 |
| mold contamination investigations | 0.792188 |
| house dust mites | 0.853096 |
| lung cancer | 0.822974 |
| Breathing asbestos fibers | 0.779558 |
| children | 0.82003 |
| mold spores | 0.817027 |
| mold growth | 0.870755 |
| mold remediation efforts | 0.786836 |
| soil air entry | 0.78118 |
| indoor environmental asthma | 0.798634 |
| intrinsic asthma | 0.787787 |
| asthma | 0.812385 |
| harmful indoor air | 0.792714 |
| indoor air pollutants | 0.869163 |
| exposure | 0.825226 |
| mold contamination | 0.812229 |
| indoor formaldehyde levels | 0.781815 |
| health effects | 0.82264 |
| asbestos | 0.837904 |
| air conditioning | 0.788606 |
|
| United States | 0.848387 |
| asbestos fibers | 0.825148 |
| mold abatement strategies | 0.78996 |
| asbestos material | 0.827123 |
| asbestos exposure | 0.790341 |
| airborne mold spores | 0.795378 |
| indoor air pollution | 0.865799 |
| low indoor air | 0.792278 |
| indoor mold distributions | 0.816397 |
| indoor air contaminants | 0.792292 |
| Mold Assessment Methods | 0.795949 |
| biologic pollutants | 0.804029 |
| outdoor air | 0.818795 |
| toxin-producing mold | 0.778434 |
| house dust mite | 0.803763 |
| outdoor air samples | 0.780804 |
| indoor air | 0.979081 |
| home | 0.816652 |
| mold problems | 0.803142 |
| mold exposure | 0.79473 |
| mold contamination extent | 0.789396 |
| Air pollutant levels | 0.797583 |
| single mold species | 0.799174 |
| levels | 0.803659 |
|
CLICK HERE |
| 7549 |
Centers for Disease Control and Prevention |
Html |
en |
Chikungunya Outbreak - Cambodia, February-March 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| chikungunya outbreak | 0.794807 |
| Public health agencies | 0.713331 |
| Cambodia | 0.779449 |
| National Malaria Center | 0.709499 |
| recent flavivirus infection | 0.710841 |
| Reunion Island outbreak | 0.712127 |
| local health centers | 0.719794 |
| Kampong Speu Province | 0.707414 |
| Kampong Speu | 0.74213 |
| CHIKV Asian strain | 0.72947 |
| Medical Research Unit | 0.953968 |
| U.S. Naval Medical | 0.773093 |
| Ae. albopictus | 0.734987 |
| IgM seroprevalence | 0.857291 |
| infected Aedes mosquitoes | 0.70941 |
| East/Central/South African strain | 0.776134 |
| CHIKV-positive cases | 0.70746 |
| positive PCR results | 0.711731 |
| CHIKV IgM-positive prevalence | 0.730337 |
| onset date | 0.738198 |
| health planning efforts | 0.762237 |
| age groups | 0.743967 |
| persons | 0.791686 |
| CHIKV outbreak | 0.759506 |
|
| Naval Medical Research | 0.950994 |
| CHIKV IgM | 0.832389 |
| Disease Control Department | 0.712736 |
| Institut Pasteur | 0.750346 |
| CHIKV | 0.911524 |
| current self-reported symptoms | 0.717023 |
| Phnom Penh | 0.846952 |
| anti-CHIKV IgM | 0.714581 |
| age group | 0.790799 |
| asymptomatic CHIKV infection | 0.745426 |
| chikungunya virus | 0.798895 |
| village residents | 0.759646 |
| Public Health Unit | 0.714618 |
| polymerase chain reaction | 0.838374 |
| cases | 0.738638 |
| CHIKV serologic study | 0.73061 |
| joint pains | 0.759003 |
| chikungunya reemergence | 0.788795 |
| chikungunya virus infection | 0.768117 |
| debilitating joint pains | 0.70529 |
| Communicable Disease Control | 0.786998 |
| clinical attack rate | 0.75226 |
| new variant chikungunya | 0.755087 |
| CHIKV IgM seroprevalence | 0.79312 |
|
CLICK HERE |
| 7605 |
Centers for Disease Control and Prevention |
Html |
en |
Multistate Meningitis Outbreak: Healthcare Facilities |
HAIs are associated with a variety of causes, including the use of medical devices, such as catheters and ventilators, complications following a surgical procedure, transmission between patients and healthcare workers, or the result of antibiotic overuse. |
| multistate outbreak | 0.715267 |
| treatment | 0.445329 |
| Center | 0.445492 |
| CDC | 0.46906 |
| vials | 0.467804 |
| patients | 0.539331 |
| tainted steroid injections | 0.976515 |
| complete list | 0.64211 |
| patient recovery | 0.65537 |
|
| BUD | 0.620338 |
| methylprednisolone acetate | 0.651696 |
| health care facilities | 0.840394 |
| New England Compounding | 0.895623 |
| infections | 0.544169 |
| clinicians | 0.67352 |
| relevant materials | 0.65122 |
| page | 0.443383 |
| web resources | 0.680139 |
|
CLICK HERE |
| 7680 |
Centers for Disease Control and Prevention |
Html |
en |
Microscopic Gallery of Pathologic Results - Laboratory Guidance |
Multistate Outbreak of Human Salmonella Hadar Infections Linked to Live Poultry |
| basilar artery | 0.892463 |
| multistate outbreak | 0.584314 |
| suppurative vasculitis | 0.565066 |
| Multistate Fungal Meningitis | 0.815575 |
| treatment | 0.422586 |
| clinical findings | 0.557705 |
| CDC | 0.426139 |
| clinical cases | 0.520842 |
| complication present | 0.524092 |
| tissue | 0.445488 |
| affected site | 0.529546 |
| patient recovery | 0.53701 |
| giant cell arteritis | 0.637563 |
| thrombosis | 0.428664 |
| immunohistochemistry facilitates | 0.539025 |
| silver stain | 0.640453 |
| Outbreak Investigation | 0.547322 |
| infections | 0.458222 |
| necrotic debris | 0.535066 |
| relevant materials | 0.529017 |
| vessel walls | 0.516007 |
|
| web resources | 0.5397 |
| pathological findings | 0.574415 |
| Center | 0.422622 |
| affected joints | 0.533784 |
| focal detection | 0.517927 |
| Major histopathologic findings | 0.685532 |
| spinal meningitis | 0.580547 |
| oxidation times | 0.518068 |
| purulent exudate | 0.516218 |
| GMS | 0.426843 |
| tainted steroid injections | 0.685951 |
| patientsand clinicians | 0.553105 |
| arthritis | 0.421099 |
| necrosis | 0.444182 |
| New England Compounding | 0.65854 |
| Arachnoiditis | 0.434028 |
| fungal hyphae | 0.908338 |
| polyfungal immunohistochemistry reagent | 0.647406 |
| inflammatory infiltrate | 0.532808 |
| page | 0.441303 |
|
CLICK HERE |
| 8985 |
Centers for Disease Control and Prevention |
Video |
en |
Bill's Ad: Smoking and Diabetes - Video |
Bill had diabetes and he used to smoke. Cigarette smoking made his diabetes much worse. In this TV spot from CDC's Tips From Former Smokers campaign, Bill explains the serious health problems he developed by age 40, including kidney failure, blindness in one eye, and a leg amputated due to poor circulation. Bill suggests that smokers make a list of everything they are willing to give up if they continue to smoke. Bill died from heart disease at age 42.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
http://streaming.cdc.gov/vod.php?id=c3da9b79d9bc2939b347cefa380c4eec20130318110151292 |
| Smokers | 0.917697 |
| CDC | 0.901732 |
| Diabetes | 0.764969 |
|
| YouTube | 0.855994 |
| Smoking | 0.767333 |
|
CLICK HERE |
| 13477 |
Centers for Disease Control and Prevention |
Html |
en |
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015 | 16 Influenza Season |
Lisa A. Grohskopf, MD1; Leslie Z. Sokolow, MSc, MPH1,2; Sonja J. |
| ACIP Influenza Work | 0.574329 |
| licensed influenza vaccines | 0.573904 |
| influenza vaccine product | 0.599297 |
| quadrivalent influenza vaccine | 0.634145 |
| Influenza Vaccine Effectiveness | 0.588543 |
| inactivated influenza vaccines | 0.573275 |
| U.S. seasonal influenza | 0.598765 |
| influenza disease | 0.52758 |
| various influenza vaccine | 0.635509 |
| live attenuated influenza | 0.563985 |
| vaccine virus | 0.487265 |
| children | 0.523345 |
| IIV vaccine effectiveness | 0.498535 |
| trivalent influenza vaccines | 0.577797 |
| available influenza vaccines | 0.569935 |
| advisory committee | 0.484043 |
| stratis injector | 0.499218 |
| Lisa A. Grohskopf | 0.48171 |
| Quadrivalent influenza vaccines | 0.576377 |
| influenza illness | 0.526986 |
| influenza vaccine products | 0.65703 |
| seasonal influenza vaccines | 0.650334 |
| predominant influenza | 0.527004 |
|
| influenza vaccine | 0.912459 |
| influenza season | 0.594367 |
| influenza vaccines | 0.787697 |
| influenza activity | 0.541006 |
| well-matched influenza viruses | 0.543888 |
| Vaccine Dose Considerations | 0.499903 |
| recombinant influenza vaccine | 0.631828 |
| influenza vaccine components | 0.583611 |
| Vaccine Adverse Event | 0.483236 |
| H3N2 influenza viruses | 0.543477 |
| egg-based influenza vaccines | 0.558499 |
| influenza complications | 0.519485 |
| influenza virus circulation | 0.567306 |
| ACIP recommendations | 0.491809 |
| inactivated influenza vaccine | 0.645584 |
| Influenza Division | 0.513869 |
| influenza viruses | 0.582268 |
| annual influenza vaccination | 0.576821 |
| influenza B virus | 0.548428 |
| influenza virus | 0.570039 |
| culture-confirmed influenza | 0.547353 |
| LAIV4 vaccine effectiveness | 0.491004 |
|
CLICK HERE |